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Background: Antibiotics are among the drugs most commonly prescribed to children in hospitals and communities.
Unfortunately, a great number of these prescriptions are unnecessary or inappropriate. Antibiotic abuse and misuse
have several negative consequences, including drug-related adverse events, the emergence of multidrug resistant
bacterial pathogens, the development of Clostridium difficile infection, the negative impact on microbiota, and
undertreatment risks. In this paper, the principle of and strategies for paediatric antimicrobial stewardship (AS)
programs, the effects of AS interventions and the common barriers to development and implementation of AS
programs are discussed.
Discussion: Over the last few years, there have been significant shortages in the development and availability of new
antibiotics; therefore, the implementation of strategies to preserve the activity of existing antimicrobial agents has
become an urgent public health priority. AS is one such approach. The need for formal AS programs in paediatrics was
officially recognized only recently, considering the widespread use of antibiotics in children and the different
antimicrobial resistance patterns that these subjects exhibit in comparison to adult and elderly patients. However,
not all problems related to the implementation of AS programs among paediatric patients are solved. The most
important remaining problems involve educating paediatricians, creating a multidisciplinary interprofessional AS
team able to prepare guidelines, monitoring antibiotic prescriptions and defining corrective measures, and the
availability of administrative consensuses with adequate financial support. Additionally, the problem of optimizing
the duration of AS programs remains unsolved. Further studies are needed to solve the above mentioned problems.
Conclusions: In paediatric patients, as in adults, the successful implementation of AS strategies has had a significant
impact on reducing targeted- and nontargeted-antimicrobial use by improving the quality of care for hospitalized
patients and preventing the emergence of resistance. Considering that rationalization of antibiotic misuse and abuse is
the basis for reducing emergence of bacterial resistance and several clinical problems, all efforts must be made to
develop multidisciplinary paediatric AS programs in hospital and community settings.
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Antibiotics are among the drugs most commonly pre-
scribed to children in hospital and community settings
[1–3]. It has been reported that the average proportion
of children in hospital settings who receive at least one
antibiotic is between 33 % and 78 % [4–8]. Moreover,
antibiotics are prescribed during approximately 20 % of
paediatric ambulatory visits [9]. Unfortunately, a great
number of these antibiotic prescriptions are unnecessary
or inappropriate. Frequently, antibiotics are administered* Correspondence: susanna.esposito@unimi.it
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non-infectious diseases [10–12]. In other cases, broad-
spectrum antibiotics are given to children who suffer
from infections for which narrow-spectrum drugs are in-
dicated and recommended [9, 11]. Finally, many children
receive antibiotic prescriptions indicating an incorrect
total daily dosage or fractioning or for a period of time
significantly longer than needed [4, 10–14].
Antibiotic abuse and misuse have several negative con-
sequences. The incidence of drug-related adverse events is
significantly increased in instances of improper antibiotic
use [15, 16]. Moreover, the emergence of multidrug re-
sistant bacterial pathogens is heavily favoured in such
instances, leading to longer hospital stays, increasedle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Antimicrobial stewardship strategies in paediatric
settings
Main Strategies
Review and analyse antibiotic use after they have been prescribed
Reach consensus on antibiotic use before they are prescribed
Problems that must be considered for rational antibiotic use
Prompt initiation of antibiotic use when indicated
Avoiding use of antibiotics for conditions not due to bacteria
Choice of the first and second line drugs for the demonstrated or
supposed bacterial etiology responsible for the disease that requires
treatment
Identification of proper dose, fractioning, and duration of antibiotic
and switch from intravenous to per os according to the patient and
the disease
Choice of conditions for which antibiotic prophylaxis is needed
Methods to rationalize antibiotic therapy
Education (i.e., lectures, handbooks, educational conferences,
guidelines)
Use of antibiotic order forms
Formation of multidisciplinary antimicrobial stewardship team
Obtaining administrative and leadership support
Continuous and transparent monitoring of antibiotic use
Adequate use of diagnostic tests, including point-of-care tests
Knowledge of local resistance rates for different pathogens
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Other important problems related to antibiotic abuse and
misuse are represented by the increasing incidence in
Clostridium difficile infection [17, 18] and the negative im-
pact on microbiota [19, 20]. Inappropriate dosage may
also be associated with undertreatment risks [21].
In the last 15 years, significant deficiencies have oc-
curred in the development and availability of new antibi-
otics able to combat instances of emerging resistance
[22]; therefore, the implementation of strategies to pre-
serve the activity of existing antimicrobial agents has be-
come an urgent public health priority. Antimicrobial
stewardship (AS) is one such approach. In this paper,
the principle of and strategies for paediatric AS pro-
grams, the effects of AS interventions and the common
barriers to development and implementation of AS pro-
grams are discussed.
Discussion
Principle of and strategies for antimicrobial stewardship
programs in paediatrics
For several years, AS efforts were focused on adult popu-
lations. A very successful and evidence-based AS program
in adults was the Transatlantic Taskforce on Antimicrobial
Resistance, established by American President Barack
Obama and President of the European Union (EU) Fredrik
Reinfeldt from Sweden [23]. Recommendations fell into
three broad categories: urgent antimicrobial resistance is-
sues focused on appropriate therapeutic use of antimicro-
bial drugs in the medical and veterinary communities,
prevention of both healthcare- and community-associated
drug-resistant infections, and strategies for improving the
pipeline of new antimicrobial drugs.
The need for formal AS programs in paediatrics was
officially recognized only recently, considering the wide-
spread use of antibiotics in children and the different
antimicrobial resistance patterns that these subjects ex-
hibit in comparison to adult and elderly patients [24].
In the United States, the Infectious Disease Society of
America (IDSA) published guidelines for developing an
institutional program to enhance AS and identified
paediatrics as a priority area for further research re-
garding the effectiveness of AS activities [25]. Later, the
Pediatric Infectious Diseases Society in 2010 [26] and
the American Academy of Pediatrics in 2012 [27] both
highlighted the importance of AS in paediatrics; these
organizations promoted research, developed educational
programs, and recommended implementation of AS pro-
grams in health care organizations that provide inpatients
and outpatients with paediatric care. After these recom-
mendations, the number of hospitals in which AS pro-
grams have been developed and tested significantly grew.
In a study recently carried out in the United States, it was
found that 31 out of 42 children’s hospitals that aremembers of the Children's Hospital Association had a
formal AS program or were in the process of implement-
ing a program [27]. Moreover, some attempts to introduce
AS in ambulatory setting have been made [28].
From a theoretical point of view, to be maximally ef-
fective in rationing antibiotic prescriptions, AS strategies
and protocols must account for several elements strictly
related to the antibiotic prescription but should also
consider the need for continuous access to expertise in
clinical pharmacology and infectious diseases and for
transparent monitoring of antibiotic use (Table 1). Prac-
tically, two main core strategies are utilized, which are a
prospective audit with feedback and a prior approval
strategy. In the first strategy, reviews of prescriptions
with feedback on antibiotics used are performed after
the antibiotics have been prescribed. In the second, reviews
and approvals of antibiotic prescriptions are made prior
to the initiation of therapy [24]. Additional possibilities
to supplement core strategies or to improve antibiotic
prescribing methods include education of providers,
guidelines, streamlining/de-escalation therapy, intravenous-
oral conversion, dose optimization, and use of antimicrobial
order forms [26, 28]. Educational programs are particularly
important [26]. They should provide adequate information
about the rules for the identification of patients for whom
antibiotics are necessary, the optimal timing of drug admin-
istration and the most appropriate antibiotic regimen with
the time of de-escalation or discontinuation specified.
Goldman et al. retrospectively studied antibiotic prescrip-
tions made over 5 years in a paediatric hospital in the
United States and found that community-acquired pneu-
monia and ear/nose/throat infections were the diagnoses
with the highest predictive probability of warranting an
AS program recommendation, whereas fever/neutropenia
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gle strategies can be effective, the best results with the
highest reduction in antibiotic misuse are usually ob-
tained when combined instead of single-strategy ap-
proaches are used [30].
With regards to the problem of selection of the appro-
priate antibiotic regimen for each child, it must be con-
sidered that for many paediatric infectious diseases, one
of a limited number of bacterial pathogens is usually the
etiologic cause and that, lacking direct microbiological
evidence, the antibiotic of choice to treat each disease is
the one active against the most probable infectious agent.
To solve the problem of the delay with which culture re-
sults indicate the etiology of a given disease, the use of
rapid diagnostic tests must be considered [31]. Moreover,
a thorough understanding of the local rates of resistance
to different pathogens is essential, and an automated up-
date of empiric antimicrobial prescription guidelines must
be planned [28, 32, 33].
The questions of the appropriate dosage and timing of
antibiotic administration can be resolved by restricting
formulary for empiric treatment to 48–72 h to permit a
re-evaluation of the prescribed therapy and a decision as
to whether the therapy should be continued, modified or
suspended. However, in planning AS programs, particu-
lar attention must be paid to drugs that have been found
to be predictive of receiving paediatric AS recommenda-
tions. In their study, Goldman et al. reported that third-
generation cephalosporins and clindamycin were the an-
timicrobials with the highest predictive probability of
warranting an AS program recommendation, whereas li-
nezolid had the lowest probability [29]. Moreover, in
children receiving antibiotics frequently associated with
severe adverse events, monitoring of drug levels can be
an opportunity to assure adequate treatment [26].
Development of local AS teams including experts from
different fields is considered essential to ensure adequate
development of AS programs and continuously updated
information useful for avoiding antibiotic misuse and
abuse [26]. Infectious disease, pharmacy, microbiology,
infection control, and information technology specialists
need to be involved and offer support and continuous
medical education to paediatricians regarding the pre-
scription of antibiotics. The hospital administration and
medical staff leadership must also contribute, even with
financial support, to the application of AS programs [26].
Implementation of paediatric AS programs is easier in
the hospital setting, where technical and human resources
are more plentiful and easily available than in the commu-
nity. Hyun et al. have listed potential strategies to promote
AS programs in community-based settings, highlighting
the need for identification of local physician champions
and potential resources (i.e., pharmacy records, infec-
tion control practitioners, pharmacists, microbiologists,microbiology results, information technology) as well
as the great difficulties in developing common guide-
lines for antibiotic use and control [34].
Although AS programs should account for all the as-
pects previously discussed, in most previously imple-
mented programs, the development and implementation
were only partial. A relevant example is provided by the
study published by Bryant on behalf of the Australasian
Stewardship of Antimicrobials in Paediatrics group [35].
Fourteen tertiary paediatric hospitals were surveyed, and
it was found that all of them had empirical guidelines for
prescribing antimicrobials. However, most of the hospitals
did not have guidelines for antifungal prophylaxis, surgical
prophylaxis, neonatology or paediatric intensive care. All
hospitals had restricted drugs, but only four had electronic
approval systems. Auditing methods varied widely but
were mostly ad hoc, with feedback on results given in an
untargeted way. There was a paucity of AS education: no
hospitals provided education for senior medical staff, and
four had no education for any staff.
Impact of antimicrobial stewardship programs in paediatrics
Several evaluations of paediatric AS programs have
shown favourable outcomes, including a reduction in
antibiotic prescriptions and lower costs (Table 2). Most
of these evaluations were performed in hospitals, prob-
ably due to the difficulties in performing AS outside this
setting. Among the studies concerning hospitalized chil-
dren, those by Agwu et al. [36], Metjian et al. [37], and
Di Pentima et al. [38] deserve attention.
Agwu et al. evaluated a World Wide Web-based anti-
microbial restriction program at a 175-bed, tertiary care
paediatric teaching hospital [36]. The program provided
automated clinical decision support, facilitated approval,
and enhanced real-time communication among prescribers,
pharmacists, and paediatric infectious disease fellows. After
implementation of the program, there was a $370,069 re-
duction in projected annual costs associated with restricted
antimicrobial use and an 11.6 % reduction in the number
of dispensed doses. User satisfaction increased from
22–68 % and from 13–69 % among prescribers and
pharmacists, respectively. There were 21 % and 32 %
reductions in the number of prescriber reports of
missed and delayed doses, respectively, and there was a
37 % reduction in the number of pharmacist reports of
delayed approvals [36].
Metjian et al. performed a prospective observational
study in which data were collected on clinician's re-
quests for targeted antibiotics and the interventions
made by an AS program [37]. During the 4-month study
period, calls were placed to the AS program for 652
patients. Forty-five percent of those calls required an
intervention by the AS program. These interventions
included targeting the known or suspected pathogens
Table 2 Main studies on the impact of antimicrobial stewardship programs in paediatric settings
Author and year of publication Site of evaluation Strategy Type of control Main results
Agwu et al., 2008 [36] Single hospital World Wide Web-based antimicrobial
restriction program, automated clinical
decision support, facilitated approval,
enhanced real-time communication
among prescribers, pharmacists, and
paediatric infectious disease fellows
Before and after implementation
of the program, evaluation of user
satisfaction, reports of missed
and/or delayed doses, antimicrobial
dispensing times and costs
Satisfaction increased from 22–68 % and
from 13–69 % among prescribers and
pharmacists, respectively. Reductions of
21 % and 32 % in the number of missed
and delayed antimicrobial doses, respectively
$370,069 reduction in projected annual costs
Metjian et al., 2008 [37] Single hospital Evaluation of outcomes and compliance
resulting from empirical antibiotic therapy
decisions
Intervention to modify antibiotic
therapy
45 % of prescriptions required an intervention.
Di Pentima et al., 2011 [38] Single hospital Antimicrobial use indications were included
as a mandatory field in the computerized
information system
Prescriptions were reviewed by
specialists
Reduction in antimicrobials of more than 30 %
for both targeted and nontargeted drugs
Hersh et al., 2015 [39] Nine hospitals Antimicrobial consumption after introduction
of an antimicrobial stewardship program
defined as a program able to continuously
monitor use with the support of a dedicated
team in some hospitals
Evaluation of days of therapy per
1,000 patient-days
Decline in average antibiotic use in hospitals
with antimicrobial stewardship program of
11 % vs 8 % in those without the program
Filkelstein et al., 2008 [40] The community
(16 non-overlapping
communities)
Guideline dissemination, small-group education,
frequent updates, education material for
paediatricians and parents
Consumption of antibiotics The intervention had no effect among children
aged 3–23 months but was associated with a
4 % and 7 % decrease in antibiotic prescriptions
in those aged 24–47 months and 48–71 months,
respectively.
Gerber et al., 2013 [41] The community
(162 clinicians)
One 1-h on-site education session followed by
one year of personalized quarterly audits and
feedback on prescriptions for respiratory
infections or usual practice in a group of
enrolled individuals
Consumption of antibiotics Broad spectrum antibiotic prescriptions decreased
from 27 % to 14 % among intervention practices
and from 28 % to 23 % in controls.
Off-guideline prescriptions decreased from 16 %
to 4 % among intervention practices compared
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treatment (33 %), and stopping the antimicrobial treat-
ment (4 %). Three of the 84 (3.5 %) patients recommended
to receive an alternative therapy developed an infection
not covered by the AS recommendations or the anti-
microbial initially requested by the clinician [37].
Di Pentima et al. reported the results of an AS pro-
gram carried out in a paediatric teaching hospital in
Tennessee, USA [38]. An automated report of antimi-
crobials prescribed, doses, patient demographics, and
microbiology data were generated and reviewed by an
infectious disease pharmacist and a paediatric infectious
disease physician. Antimicrobial use, expressed as the
number of doses administered per 1,000 patient-days,
was measured 3 years before and 3 years after the imple-
mentation of the program. Total antimicrobial use
peaked at 3,089 doses administered per 1,000 patient-
days per year in the last period before implementation of
the program and decreased to 1,904 doses administered
per 1,000 patient-days per year during the last post-
intervention period [38]. Targeted-antimicrobial use de-
clined from 1,250 to 988 doses administered per 1,000
patient-days per year. Nontargeted-antimicrobial use de-
clined from 1,839 to 916 doses administered per 1,000
patient-days per year. Rates of antimicrobial resistance
to broad-spectrum antimicrobials among the most com-
mon Gram-negative bacilli remained low and stable over
time [38].
However, all of these studies were single-centre studies
and were carried out over a limited period of time. For
these reasons, they can be criticized because they are
subject to multiple biases, including publication bias, a
failure to consider secular trends in antibiotic use and a
lack of comparisons with antibiotic prescriptions in simi-
lar hospitals without AS programs. The study by Hersh
et al. overcame these limits, confirming the effectiveness
of AS programs in children and the need for their sys-
tematic use in all paediatric hospitals [39]. These authors
compared antibiotic prescription rates in a group of nine
paediatric hospitals with formal AS programs to corre-
sponding rates in a group of 22 control hospitals without
formal AS programs. The impact of AS on antibiotic
prescriptions was measured by days of therapy/1,000
patient-days during the period from 2004–2012 before
and after the release of 2007 IDSA guidelines for devel-
oping AS programs. Antibiotic use was compared for all
antibacterials and for a select subset (i.e., vancomycin,
carbapenems, linezolid). In comparison with the decline
observed in those years preceding the guidelines, there
was a larger post-guideline decline in average antibiotic
use in hospitals with AS programs than in hospitals
without them (11.0 % vs 8.0 %, respectively; p = 0.04).
Because the decline in antibiotic use was lower in the
pre-implementation period (5.7 %), it was concluded thatthese results provide evidence that the reduction was
greater than the concurrent secular trend and supported
the value of AS programs.
Outpatient AS interventions are uncommon. However,
the available data seem to indicate that AS can be effect-
ive in reducing antibiotic misuse in community settings
as well, although the results are less impressive than those
obtained in hospitals. From 1998–2003 Finkelstein et al. con-
ducted a controlled, community-level, cluster-randomized
trial in 16 non-overlapping Massachusetts communities
[40]. During the winter periods of these 3 years, some
of these communities implemented a physician behaviour-
change strategy that included guideline dissemination,
small-group education, frequent updates and educational
materials, and feedback on prescriptions. Moreover,
parents of children living in these communities received
educational materials by mail and in primary care prac-
tices, pharmacies, and child care settings. No intervention
was planned in the remaining communities. The number
of antibiotics dispensed per person-year of observation
among children aged 3 to <72 months who resided in the
study communities was evaluated. A substantial down-
ward trend in antibiotic prescriptions, even in the absence
of the intervention, was observed. The intervention had
no additional effect among children aged 3 to <24 months
but was responsible for a 4.2 % decrease in antibiotic pre-
scriptions among those aged 24 to <48 months and a
6.7 % decrease among those aged 48 to <72 months [40].
The intervention effect was greater for broad-spectrum
agents.
More recently, Gerber et al. performed an outpatient
AS interventional trial that involved 162 clinicians and
consisted of a 1-h on-site clinician education session
followed by one year of personalized quarterly audits of
and feedback on prescriptions for acute respiratory tract
infections or usual practice [41]. Broad-spectrum anti-
biotic prescriptions decreased from 26.8 % to 14.3 %
among intervention practices and from 28.4 % to 22.6 %
in control settings (p = 0.01). Off-guideline prescriptions
for children with pneumonia decreased from 15.7 % to
4.2 % among intervention practices compared with a
decrease from 17.1 % to 16.3 % in control practices
(p < 0.001). However, no significant differences were
observed for acute rhinosinusitis; off-guideline pre-
scriptions for this condition declined from 38.9 % to
18.8 % in intervention practices and from 40.0 % to
33.9 % in control facilities (p = 0.12). Off-guideline
prescriptions were uncommon at baseline and changed lit-
tle for streptococcal pharyngitis (intervention, from 4.4 %
to 3.4 %; control, from 5.6 % to 3.5 %; p = 0.82) and for
viral infections (intervention, from 7.9 % to 7.7 %; control,
from 6.4 % to 4.5 %; p = 0.93) [41].
One of the most successful interventions to reduce
antibiotic prescriptions among children in outpatient
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1992–2014, the total consumption of antibiotics has de-
creased by 41 %. The greatest decrease during these
years has been in the 0–4 year age group, where sales
decreased by 75 %, from 1,328 in 1992 to 328 prescrip-
tions per 1,000 inhabitants in 2014.
Barriers to the development and implementation of
antimicrobial stewardship programs
Despite a growing evidence base supporting the value of
paediatric AS programs, a number of well-recognized
barriers hinder their development and growth. A lack of
knowledge regarding the fundamental rules on which
antibiotic prescriptions are based remains one of the
most important problems in the implementation of AS
programs. A recent study by Bowes et al. highlighted
several challenges that paediatric practitioners face with
respect to the knowledge of and approaches to prescrib-
ing antimicrobials [43]. In particular, these authors re-
ported that the majority of physicians included in a
survey they carried out in a Canadian teaching hospital
did not receive any formal education regarding the pre-
scribing of antimicrobials and antimicrobial stewardship
in the previous year. Moreover, both the trainees and the
staff had modest knowledge of factors that would in-
crease the risk of resistance, and less than 20 % of them
had correct knowledge of local resistance patterns for
common bacteria [43].
All of these findings provide evidence that educational
programs specifically devoted to illustrate the rules for
rational use of antibiotics are needed before and during
AS program implementation. Guidelines and protocols
can be useful in this regard, but to be most effective,
these should be shared between all specialists directly
or indirectly involved in the prescription of antibiotics,
including pharmacists, microbiologists, and infectious
disease specialists. Shared suggestions for antibiotic ad-
ministration can permit a facility to overcome the risk
of any new intervention being perceived by front-line
physicians as interfering with their routine practice and
being questioned. Unfortunately, creation of a team
specifically dedicated to educate providers and monitor
antibiotic use to correct possible mistakes is not always
possible because it requires substantial financial sup-
port. A lack of funds can cause difficulties in the imple-
mentation of an AS program. Additionally, a lack of
technical resources may further limit the implementation
and effectiveness of AS programs. Daily surveillance of
antibiotic prescriptions and control of the concordance
between actual and suggested uses, including evaluations
of dosing and length of administration, are largely facil-
itated by the availability of computerized programs.
Availability of hardware and software needed for monitor-
ing first requires financial support and administrativeconsensus, which is not easily obtained, even though cost
saving is routinely achieved by reducing unnecessary anti-
biotic use and decreases in the pharmacy budget usually
cover the expenses for AS program implementation
within a few months [44].
Future areas of research
As recently indicated by the updated IDSA guidelines
for implementing an AS program [45], passive didactic
education and facility-specific clinical practice guidelines
are only useful complement of a global AS intervention
and have to be associated with control measures of anti-
biotic use that can modify the debatable prescriptions.
The importance of these interventions is clearly evidenced
by a recent evaluation of the antibiotic use in paediatrics
carried out in Italy [46]. In this country, since long time
several initiatives to improve paediatrician’s education on
antibiotic use for the most common paediatric infections
have been made [47–49], but no control of guidelines im-
pact with feedback to clinicians assessing the appropriate-
ness of continuing antibiotic therapy has been performed.
The recent evaluation of antibiotic prescriptions in several
Italian pediatric departments has shown an over-use of
broad-spectrum antibiotics such as third generation
cephaloporins and carbapenems for both prophylaxis and
treatment [46]. Future areas of research should try to link
antimicrobial resistance to antibiotic prescriptions analys-
ing the impact of AS programes in paediatric care.
Conclusions
Among adult patients, the successful implementation of
AS strategies have had a significant impact on reducing
targeted- and nontargeted-antimicrobial use, improving
quality of care of hospitalized patients and preventing
the emergence of resistance. Similar results have also been
reported in paediatric patients, although there has been
significantly less widespread implementation of AS pro-
grams among children. However, not all of the problems
related to implementation of AS programs in paediatric
settings are solved. The most important remaining
problems involve educating paediatricians, creating a
multidisciplinary interprofessional AS team able to pre-
pare guidelines, monitoring antibiotic prescriptions and
defining corrective measures, and the availability of ad-
ministrative consensuses with adequate financial support.
Additionally, the problem of optimizing the duration of
AS programs remains unsolved. It is not clear whether
such programs must be maintained continuously or can
instead be implemented until rationalization of antibiotic
use is obtained and re-initiated when significant variations
in antibiotic use are needed. Some reports, including the
recent experience of Gerber et al. in a community setting
[50], seem to indicate that AS program discontinuation is
dangerous because without monitoring, antibiotic use
Principi and Esposito BMC Infectious Diseases  (2016) 16:424 Page 7 of 8tends to revert to the initial levels. Further studies are
needed to solve the above mentioned problems. However,
considering that rationalization of antibiotic misuse and
abuse is the basis for reducing emergence of bacterial re-
sistance, all efforts must be made to develop multidiscip-
linary paediatric AS programs.
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